1.

Which of the following is an NSAID for Alzheimer’s disease, that lead to Phase III clinical trials?(a) Bapineuzumab(b) Alzhemed(c) Flurizan(d) DoxilI had been asked this question in an interview.I would like to ask this question from Chemical Basis of Life topic in portion Chemical Basis of Life of Cell Biology

Answer»

The correct answer is (C) Flurizan

Explanation: Flurizan was the non-steroidal anti-inflammatory drug or NSAID for treating ALZHEIMER’s which REACHED the STAGE of phase III clinical trials but could proceed THEREAFTER.



Discussion

No Comment Found

Related InterviewSolutions